Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

L-asparaginase fatal toxic encephalopathy during consolidation treatment in an adult with acute lymphoblastic leukemia.

Frantzeskaki F, Rizos M, Papathanassiou M, Nikitas N, Lerikou M, Armaganidis A, Dimopoulos G.

Am J Case Rep. 2013 Aug 14;14:311-4. doi: 10.12659/AJCR.889268. eCollection 2013.

2.

Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia.

Kieslich M, Porto L, Lanfermann H, Jacobi G, Schwabe D, Böhles H.

J Pediatr Hematol Oncol. 2003 Jun;25(6):484-7.

PMID:
12794528
3.

Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study.

Petersdorf SH, Kopecky KJ, Head DR, Boldt DH, Balcerzak SP, Wun T, Roy V, Veith RW, Appelbaum FR.

Leukemia. 2001 Feb;15(2):208-16.

PMID:
11236936
4.
5.

L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.

Hourani R, Abboud M, Hourani M, Khalifeh H, Muwakkit S.

Neuropediatrics. 2008 Feb;39(1):46-50. doi: 10.1055/s-2008-1076740.

PMID:
18504683
6.

Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study.

Amylon MD, Shuster J, Pullen J, Berard C, Link MP, Wharam M, Katz J, Yu A, Laver J, Ravindranath Y, Kurtzberg J, Desai S, Camitta B, Murphy SB.

Leukemia. 1999 Mar;13(3):335-42.

PMID:
10086723
7.

[MRI abnormalities of the brain in neurologic complications following treatment of cancer in children].

Tomura N, Sashi R, Hashimoto M, Hirano H, Sato K, Hirano Y, Watarai J, Watanabe A.

No To Shinkei. 1996 Jul;48(7):623-30. Japanese.

PMID:
8752996
8.

Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.

Hunault-Berger M, Chevallier P, Delain M, Bulabois CE, Bologna S, Bernard M, Lafon I, Cornillon J, Maakaroun A, Tizon A, Padrazzi B, Ifrah N, Gruel Y; GOELAMS (Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang).

Haematologica. 2008 Oct;93(10):1488-94. doi: 10.3324/haematol.12948. Epub 2008 Aug 25.

9.
10.

Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase.

Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krähenbühl S.

Digestion. 2006;74(1):28-32. Epub 2006 Sep 19.

PMID:
16988508
11.

Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.

Place AE, Stevenson KE, Vrooman LM, Harris MH, Hunt SK, O'Brien JE, Supko JG, Asselin BL, Athale UH, Clavell LA, Cole PD, Kelly KM, Laverdiere C, Leclerc JM, Michon B, Schorin MA, Welch JJ, Lipshultz SE, Kutok JL, Blonquist TM, Neuberg DS, Sallan SE, Silverman LB.

Lancet Oncol. 2015 Dec;16(16):1677-90. doi: 10.1016/S1470-2045(15)00363-0. Epub 2015 Nov 6.

PMID:
26549586
12.

L-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia.

Rathi B, Azad RK, Vasudha N, Hissaria P, Sawlani V, Gupta RK.

Pediatr Neurosurg. 2002 Oct;37(4):203-5.

PMID:
12372914
13.

Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Salzer WL, Devidas M, Shuster JJ, Wang C, Chauvenet A, Asselin BL, Camitta BM, Kurtzberg J; Children's Oncology Group.

J Pediatr Hematol Oncol. 2007 Jun;29(6):369-75.

PMID:
17551397
14.

Surgical pancreatic complications induced by L-asparaginase.

Sadoff J, Hwang S, Rosenfeld D, Ettinger L, Spigland N.

J Pediatr Surg. 1997 Jun;32(6):860-3.

PMID:
9200086
15.

Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy.

Saviola A, Luppi M, Potenza L, Morselli M, Bresciani P, Ferrari A, Riva G, Torelli G.

Eur J Haematol. 2004 Jan;72(1):71-2.

PMID:
14962268
16.

Hepatomegaly and fever at the time of neutrophil recovery revealing L-asparaginase toxicity in the treatment of acute lymphoblastic leukemia.

Saison J, Berger F, Lebosse F, Audoual R, Thomas X, Michallet M.

Am J Case Rep. 2014 Jan 12;15:13-7. doi: 10.12659/AJCR.889867. eCollection 2014.

17.

Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.

Tsukamoto S, Takeuchi M, Kawajiri C, Tanaka S, Nagao Y, Sugita Y, Yamazaki A, Kawaguchi T, Muto T, Sakai S, Takeda Y, Ohwada C, Sakaida E, Shimizu N, Yokote K, Iseki T, Nakaseko C.

Int J Hematol. 2012 Feb;95(2):204-8. doi: 10.1007/s12185-011-0982-9. Epub 2011 Dec 9.

PMID:
22160836
19.

Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia.

Mitchell LG, Halton JM, Vegh PA, Barr RD, Venneri T, Pai KM, Andrew ME.

Am J Pediatr Hematol Oncol. 1994 May;16(2):120-6.

PMID:
8166364
20.

Acute central nervous system complications and ammonium levels in adult patients with acute lymphoblastic leukemia receiving l-asparaginase.

Strickler N, Balabanov S, Casauro K, Schanz U, Manz MG, Gerber B.

Leuk Lymphoma. 2017 Jul 21:1-8. doi: 10.1080/10428194.2017.1352090. [Epub ahead of print]

PMID:
28728499

Supplemental Content

Support Center